background
tradit
public
health
surveil
provid
accur
inform
typic
time
new
earli
warn
system
leverag
time
electron
data
emerg
public
health
valu
system
still
larg
unknown
object
assess
timeli
accuraci
pharmaci
sale
data
respiratori
gastrointestin
infect
determin
util
support
surveil
gastrointestin
ill
assess
timeli
prospect
retrospect
analysi
data
feed
use
compar
chronolog
characterist
data
stream
assess
accuraci
ontario
antivir
prescript
compar
confirm
case
influenza
case
influenzalikeil
ili
august
januari
nova
scotia
sale
respiratori
overthecount
product
otc
compar
laboratori
report
respiratori
pathogen
detect
januari
march
enter
outbreak
data
nova
scotia
compar
sale
gastrointestin
product
time
period
assess
util
pharmaci
sale
gastrointestin
product
monitor
across
canada
detect
unusu
increas
report
dissemin
provinc
territori
week
decemb
march
followup
evalu
survey
stakehold
conduct
result
ontario
prescript
antivir
correl
close
onset
date
magnitud
confirm
influenza
case
nova
scotia
sale
respiratori
otc
product
correl
increas
noninfluenza
respiratori
pathogen
commun
definit
correl
identifi
occurr
enter
outbreak
sale
gastrointestin
otc
nova
scotia
evalu
nation
monitor
show
signific
increas
sale
gastrointestin
product
could
link
outbreak
includ
one
provinc
territori
monitor
pharmacybas
drug
prescript
otc
sale
provid
time
accur
complement
tradit
respiratori
public
health
surveil
activ
initi
evalu
show
track
gastrointestinalrel
otc
valu
identifi
enter
diseas
outbreak
one
provinc
territori
studi
period
canada
tradit
public
health
surveil
infecti
diseas
reli
heavili
report
laboratoryconfirm
case
mechan
provid
robust
inform
may
accompani
appreci
lag
period
test
report
ill
public
health
author
result
lost
window
opportun
implement
intervent
furthermor
infecti
diseas
typic
associ
mild
moder
ill
treatment
often
empir
ie
test
done
limit
abil
laboratorybas
surveil
provid
accur
assess
ill
commun
syndrom
surveil
often
involv
big
data
base
use
nonspecif
health
indic
proxi
measur
eg
school
absente
drug
sale
telehealth
call
provid
provision
diagnosi
syndrom
data
sourc
tend
nonspecif
yet
sensit
rapid
augment
complement
inform
provid
tradit
diagnost
testbas
surveil
system
past
year
pharmacybas
surveil
emerg
new
public
health
capabl
canada
intern
public
health
agenc
canada
agenc
first
deploy
pharmacybas
syndrom
surveil
evalu
feasibl
monitor
gastrointestin
overthecount
otc
product
tool
earli
detect
commun
food
waterborn
ill
outbreak
pharmacybas
syndrom
surveil
use
agenc
respons
influenza
pandem
outbreak
retrospect
analysi
second
wave
demonstr
pharmacybas
surveil
provid
effect
mechan
monitor
detect
influenzalik
activ
faster
tradit
surveil
system
follow
pandem
pharmacybas
surveil
system
extend
determin
util
implement
agenc
surveil
strateg
plan
number
medic
track
includ
analges
antiallergi
medic
prescript
antidepress
cardiovascular
medic
object
studi
evalu
three
aspect
system
accuraci
timeli
util
pharmacybas
surveil
support
season
influenza
respiratori
ill
surveil
detect
multijurisdict
enter
diseas
outbreak
ie
involv
one
provinc
territori
data
obtain
respiratori
surveil
antivir
prescript
ontario
respiratori
otc
nova
scotia
compar
confirm
case
influenza
report
influenzalikeil
ontario
laboratori
detect
noninfluenza
respiratori
pathogen
nova
scotia
data
obtain
gastrointestin
surveil
otc
sale
product
indic
acut
gastrointestin
ill
across
canada
data
nova
scotia
compar
local
outbreak
data
report
provinci
health
author
pharmaci
data
acquisit
establish
contract
industri
partner
rx
canada
daili
prescript
sale
data
sourc
nation
pharmaci
chain
four
independ
repres
store
nationwid
overthecount
otc
data
provid
daili
six
chain
retail
repres
store
across
canada
exclud
nunavut
otc
prescript
dataset
provid
coverag
health
region
across
canada
pharmaci
product
categor
syndrom
group
product
respiratori
gastrointestin
categori
otc
sale
data
standard
store
prior
aggreg
health
unit
provinceterritori
nation
minim
effect
vari
transmiss
frequenc
timeli
store
retail
chain
proport
daili
sale
select
product
indic
acut
enter
ill
calcul
present
sale
otc
product
standard
sevenday
move
averag
gastrointestin
subcategori
divid
otc
graph
log
scale
simpl
alert
algorithm
base
standard
deviat
sevenday
move
averag
use
detect
aberr
increas
pharmaci
sale
prospect
retrospect
analysi
variou
data
feed
leverag
studi
otc
prescript
ili
laboratori
report
compar
assess
timeli
public
health
surveil
accuraci
pharmacosurveil
influenza
influenzalik
ill
assess
retrospect
analysi
compar
pharmaceut
surveil
data
surveil
data
extract
fluwatch
surveil
system
five
year
prescript
antivir
sale
ontario
compar
report
case
influenzalikeil
ili
august
januari
confirm
case
influenza
togeth
descript
analysi
spearman
correl
coeffici
rho
determin
three
time
frame
januari
decemb
novemb
march
april
octob
assess
track
accuraci
respiratori
infect
weekli
provinci
laboratori
detect
respiratori
viral
pathogen
nova
scotia
report
januari
march
evalu
rel
sale
respiratori
overthecount
product
period
respiratori
otc
data
aggreg
week
onetof
week
lag
variabl
creat
correl
use
pearson
coeffici
calcul
respiratori
otc
sale
noninfluenza
respiratori
viral
detect
rvd
test
respiratori
syncyti
viru
rsv
assess
accuraci
enter
pharmacosurveil
sale
gastrointestin
otc
compar
enter
outbreak
data
nova
scotia
use
descript
analysi
pharmaci
surveil
report
base
pharmaci
sale
gastrointestin
product
across
canada
gener
dissemin
weekli
provinci
territori
stakehold
includ
provinc
health
regionlevel
inform
trend
use
report
inform
stakehold
evalu
use
survey
develop
use
fluidsurvey
sa
stata
use
run
analyt
procedur
pharmaci
sale
data
ie
prescript
medic
otc
product
avail
near
realtim
approxim
hour
complet
transact
pharmaci
sale
data
avail
agenc
approxim
five
eight
day
earlier
ili
physician
report
day
prior
laboratori
confirm
influenza
day
earlier
report
respiratori
viral
detect
figur
depict
timelin
pharmaci
clinic
laboratori
data
rel
estim
onset
ill
avail
inform
purpos
respiratori
surveil
respiratori
surveil
weekli
dispens
prescript
antivir
medic
oseltamivir
zanamivir
proport
dispens
prescript
compar
rate
ili
case
ilitot
patient
visit
number
confirm
laboratori
report
influenza
ontario
figur
sale
antivir
correl
close
onset
date
confirm
influenza
case
spearman
rho
p
januari
decemb
novemb
march
april
octob
respect
addit
magnitud
antivir
sale
parallel
burden
confirm
case
correl
coeffici
confirm
case
ili
strong
compar
januari
decemb
rho
novemb
march
rho
april
octob
rho
report
ili
follow
trend
confirm
case
antivir
figur
howev
ili
vari
consider
late
spring
summer
result
nova
scotia
analysi
demonstr
sale
respiratori
otc
product
associ
increas
noninfluenza
respiratori
pathogen
commun
respiratori
syncyti
viru
rhinoviru
coronaviru
parainfluenza
adenoviru
human
metapneumoviru
otc
sale
correl
number
rsv
test
four
week
later
p
sale
otc
product
correl
number
respiratori
viral
detect
two
week
later
p
figur
gastrointestin
surveil
outbreak
report
nova
scotia
outbreak
due
noroviru
outbreak
primarili
persontoperson
transmiss
major
outbreak
occur
residenti
institut
definit
correl
detect
occurr
outbreak
sale
gastrointestin
otc
pilot
phase
signific
increas
sale
gastrointestin
product
detect
could
definit
link
multijurisdict
enter
outbreak
although
stakehold
respond
evalu
survey
indic
pharmaci
inform
import
jurisdict
five
jurisdict
state
use
inform
use
initi
ili
per
patient
load
influenza
case
antivir
per
prescript
investig
detect
health
event
commun
inform
clinician
use
situat
awar
nation
provinci
pharmacosurveil
appear
use
earli
detect
respiratori
ill
provinci
detect
enter
diseas
antivir
prescript
clear
marker
influenza
activ
respiratori
ill
surveil
valu
respiratoryrel
otc
less
clear
may
use
surveil
respiratori
virus
although
sale
gastrointestin
product
shown
good
marker
season
commun
noroviru
infect
valu
pharmacosurveil
outbreakrel
enter
activ
less
certain
strength
studi
includ
nation
repres
data
precis
document
pharmacosurveil
data
timeli
one
potenti
weak
includ
prescrib
medic
otc
retail
pharmaci
link
health
care
institut
exampl
although
nova
scotia
enter
outbreak
data
robust
major
noroviru
outbreak
captur
studi
period
occur
longterm
care
facil
medic
provid
longterm
care
facil
may
origin
pharmaci
contribut
sale
data
pharmaci
pilot
project
perhap
bulk
purchas
longterm
care
facil
simpli
captur
data
provid
autom
data
transfer
point
sale
support
real
near
realtim
acquisit
communityspecif
health
data
pharmaci
prescript
otc
sale
data
provid
greater
timeli
higher
geograph
resolut
nation
coverag
health
data
current
use
pharmaci
sale
data
shown
support
season
influenza
aid
decisionmak
resourc
alloc
prescript
otc
data
also
provid
earlier
window
opportun
intervent
compar
use
tradit
data
sourc
furthermor
pharmaci
data
could
use
support
surveil
action
multipl
public
health
purpos
eg
mental
health
physician
prescript
pattern
chronic
ill
multipl
agenc
differ
jurisdict
surveil
system
invest
necessari
technolog
analyt
resourc
requir
conduct
ongo
pharmacybas
syndrom
surveil
time
accur
pharmacosurveil
potenti
enhanc
public
health
capac
detect
quantifi
activ
local
multijurisdict
nation
level
research
need
determin
condit
use
compar
realtim
surveil
strategi
